Newscast – Page 176 – media

RealView integrates Intel RealSense technology into AR medical system

RealView Imaging has integrated the Intel RealSense SR300-Series camera into its holographic augmented reality (AR) medical system, Holoscope-i.
- Source: medicaldevices-network.com
- 617
- August 8, 2017
AR Company Insight medical
Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.
- Source: news-medical.net
- 539
- August 8, 2017
cancer Company Insight PET prostate tracer
Fortimedix launches short instruments for SymphonX single-port platform

Fortimedix Surgical said today it launched a shorter set of instruments for its SymphonX single-port surgical platform in the US.
- Source: Massdevice
- 537
- August 8, 2017
Company Insight instrument microlaparoscopic surgical
FDA extends review on Dynavax’s Heplisav-B

FDA extends review on Dynavax's hepatitis B vaccine candidate Heplisav-B, but both management and analysts said they remain confident in approval.
- Source: fiercepharm
- 620
- August 7, 2017
Company Insight FDA hepatitis Heplisav-B Market Views vaccine
Harvard University develops soft robotic arm for endoscopes

US researchers from Harvard University’s SEAS and the Wyss Institute for Biologically Inspired Engineering have developed a small, hybrid rigid-soft robotic arm for endoscopes.
- Source: medicaldevices-network.com
- 661
- August 7, 2017
endoscope Researches SEAS
CombiMatrix, Skyline Medical, Victory Square Technologies

The merger and acquisition information of CombiMatrix, Skyline Medical and Victory Square Technologies.
- Source: medicaldevices-network.com
- 386
- August 7, 2017
Company Insight M&A Market Views
Roche reports strong performance in the first half of 2017

Commenting on the Group’s results, Roche CEO Severin Schwan said: “In the first half of the year, both our Pharmaceuticals and Diagnostics Divisions showed strong performance, very much driven by new product launches. Particularly pleasing is the very successful launch of Ocrevus for the treatment of two forms of multiple sclerosis. Based on our half-year performance, we raised the outlook for the full-year to mid-single digit sales growth.”
- Source: www.roche.com
- 510
- August 4, 2017
Company Insight
GSK delivers further progress in Q2 and sets out new priorities for the Group

GSK delivers further progress in Q2 and sets out new priorities for the Group
- Source: www.gsk.com/
- 377
- August 4, 2017
Company Insight
Johnson & Johnson Reports 2017 Second-Quarter Results

New Brunswick, N.J. (July 18, 2017) – Johnson & Johnson (NYSE: JNJ) today announced sales of $18.8 billion for the second quarter of 2017, an increase of 1.9% as compared to the second quarter of 2016. Operational sales results increased 2.9% and the negative impact of currency was 1.0%. Domestic sales increased 1.6%. International sales increased 2.3%, reflecting operational growth of 4.4% and a negative currency impact of 2.1%. Excluding the net impact of acquisitions and divestitures, on an operational basis, worldwide sales increased 0.5%, domestic sales decreased 1.0% and international sales increased 2.0%.*
- Source: www.jnj.com
- 596
- August 4, 2017
Company Insight
MRC links with UCB in antibody initiative

The Medical Research Council (MRC) and UCB have launched a new scheme designed to help accelerate work on the development of antibody-based therapeutics.
- Source: pharmatimes
- 853
- August 4, 2017
antibody Company Insight Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.